3-fluoro-alpha-fluoromethyltyrosine has been researched along with levodopa in 1 studies
Studies (3-fluoro-alpha-fluoromethyltyrosine) | Trials (3-fluoro-alpha-fluoromethyltyrosine) | Recent Studies (post-2010) (3-fluoro-alpha-fluoromethyltyrosine) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
---|---|---|---|---|---|
5 | 0 | 2 | 17,774 | 1,900 | 4,946 |
Protein | Taxonomy | 3-fluoro-alpha-fluoromethyltyrosine (IC50) | levodopa (IC50) |
---|---|---|---|
integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balskus, EP; Bess, EN; Bisanz, JE; Maini Rekdal, V; Turnbaugh, PJ | 1 |
1 other study(ies) available for 3-fluoro-alpha-fluoromethyltyrosine and levodopa
Article | Year |
---|---|
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism.
Topics: Actinobacteria; Animals; Antiparkinson Agents; Bacterial Proteins; Decarboxylation; Dopamine; Enterococcus faecalis; Gastrointestinal Microbiome; Genome, Bacterial; HeLa Cells; Humans; Levodopa; Male; Metabolic Networks and Pathways; Mice, Inbred BALB C; Tyrosine; Tyrosine Decarboxylase | 2019 |